» Articles » PMID: 26158805

Patient-reported Side Effects, Concerns and Adherence to Corticosteroid Treatment for Asthma, and Comparison with Physician Estimates of Side-effect Prevalence: a UK-wide, Cross-sectional Study

Overview
Date 2015 Jul 10
PMID 26158805
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Non-adherence to corticosteroid treatment has been shown to reduce treatment efficacy, thus compromising asthma control.

Aims: To examine the experiences of treatment side effects, treatment concerns and adherence to inhaled (ICS) and oral corticosteroids (OCS) among people with asthma and to identify the degree of concordance between clinician estimates of side effects and the prevalence reported by patients.

Methods: Asthma UK members were sent validated questionnaires assessing treatment concerns, experiences of side effects and adherence. Questionnaires measuring clinicians' estimates of the prevalence of corticosteroid side effects were completed online.

Results: Completed questionnaires were returned by 1,524 people taking ICS, 233 taking OCS and 244 clinicians (67% of clinicians were primary care nurses). Among people with asthma, 64% of those taking ICS and 88% of those taking OCS reported ⩾ 1 side effect. People reporting high adherence to ICS (t = -3.09, P<0.005) and those reporting low adherence to OCS (t = 1.86, P < 0.05; one-tailed test) reported more side effects. There was a disparity between clinicians' estimates of the frequency of side effects and the frequency reported by people with asthma: e.g., although 46% of people taking ICS reported sore throat, clinicians estimated that this figure would be 10%. Patients who reported side effects had stronger concerns about both ICS (r = 0.46, P < 0.0001) and OCS (r = 0.50, P < 0.0001). Concerns about corticosteroids were associated with low adherence to ICS (t = 6.90, P < 0.0001) and OCS (t = 1.71; P < 0.05; one-tailed test).

Conclusions: An unexpectedly large proportion of people with asthma experienced side effects and had strong concerns about their treatment, which compromised adherence. These findings have implications for the design of interventions to optimise asthma control through improved adherence.

Citing Articles

Are Treatment Adherence Factors Apparent in Patients with Asthma and to Physicians? Results from the APPaRENT 3 Survey.

Al-Moamary M, Aggarwal B, Al-Ahmad M, Sriprasart T, Koenig S, Levy G Adv Ther. 2025; 42(3):1506-1521.

PMID: 39912987 PMC: 11868149. DOI: 10.1007/s12325-025-03105-x.


Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma.

Jones A, McDonald V, McLoughlin R, Vella T, Flynn A, Blakey J Patient Prefer Adherence. 2025; 19():75-85.

PMID: 39811764 PMC: 11730280. DOI: 10.2147/PPA.S487743.


Unlocking Better Asthma Control: A Narrative Review of Adherence to Asthma Therapy and Innovative Monitoring Solutions.

Poplicean E, Crisan A, Tudorache E, Hogea P, Mladin R, Oancea C J Clin Med. 2024; 13(22).

PMID: 39597843 PMC: 11594773. DOI: 10.3390/jcm13226699.


Prevalence of Oral Candidiasis in Asthma and COPD Patients Using Inhaled Corticosteroids in the Philippine General Hospital Department of Out-patient Services.

Arevalo J, Buban E Acta Med Philipp. 2024; 57(12):32-38.

PMID: 39429765 PMC: 11484557. DOI: 10.47895/amp.vi0.6466.


Factors Associated with Corticosteroid Adherence in Sarcoidosis.

Judson M, Ouedraogo W, Fish K, DeLuca R, Vancavage R, Sirigaddi K Lung. 2024; 202(6):785-792.

PMID: 39307901 DOI: 10.1007/s00408-024-00746-7.


References
1.
Brown C, Battista D, Bruehlman R, Sereika S, Thase M, Dunbar-Jacob J . Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med Care. 2005; 43(12):1203-7. DOI: 10.1097/01.mlr.0000185733.30697.f6. View

2.
Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B . Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000; 343(5):332-6. DOI: 10.1056/NEJM200008033430504. View

3.
Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J . Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS. 2004; 15(1):38-44. DOI: 10.1258/095646204322637245. View

4.
Partridge M, van der Molen T, Myrseth S, Busse W . Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006; 6:13. PMC: 1483837. DOI: 10.1186/1471-2466-6-13. View

5.
Barnes P, Pedersen S, Busse W . Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998; 157(3 Pt 2):S1-53. DOI: 10.1164/ajrccm.157.3.157315. View